Biotin anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
1_145-2C11_Biotin_021606
C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 1_145-2C11_Biotin_021606
    C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 2_145-2C11_Biotin_CD3e_Antibody_2_010620
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for 10 minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/ml of biotin anti-mouse CD3ε (clone 145-2C11), Alexa Fluor® 594 anti-mouse B220 (clone RA3-6B2) (blue), and Alexa Fluor® 488 anti-mouse CD29 (clone HMβ1-1) (green) overnight at 4°C, followed by 2.5 µg/ml of Spark YG™ 570 Streptavidin (red) for 2 hours at room temperature. The image was captured by 10X objective.
Compare all formats
Cat # Size Price Quantity Check Availability
100303 50 µg $42.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100304 500 µg $121.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. For immunohistochemistry, a concentration range of 5.0 - 10 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Song R, et al. 2022. Immunology. 165:274. PubMed
  3. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  4. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  5. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  6. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  7. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  8. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  9. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  10. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  11. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  12. Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed
  13. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  14. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  15. Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed
  16. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  17. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  18. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  19. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  20. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  21. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  22. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  23. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  24. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  25. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  26. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  27. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  28. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  29. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  30. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  31. Lu SX, et al. 2021. Cell. . PubMed
  32. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  33. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  34. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  35. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  36. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  37. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  38. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  39. Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed
  40. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  41. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  42. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  43. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  44. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  45. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  46. Köchl R, et al. 2020. Elife. 9:00. PubMed
  47. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  48. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  49. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  50. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  51. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  52. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  53. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  54. Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed
  55. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  56. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  57. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  58. Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed
  59. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  60. Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed
  61. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  62. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  63. Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed
  64. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  65. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  66. Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed
  67. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  68. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  69. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  70. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  71. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  72. Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed
  73. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  74. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  75. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  76. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  77. Koide S, et al. 2022. iScience. 25:103603. PubMed
  78. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  79. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  80. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  81. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  82. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  83. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  84. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  85. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  86. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  87. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  88. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  89. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  90. Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed
  91. Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed
  92. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  93. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  94. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  95. Deets KA, et al. 2021. Elife. 10:. PubMed
  96. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  97. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  98. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  99. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  100. Muro R, et al. 2015. PLoS One. 10:119898. PubMed
  101. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_312669 (BioLegend Cat. No. 100303)
AB_312669 (BioLegend Cat. No. 100304)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account